Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/17/2025

Managing Immediate Panic After Taking Qelbree

Mechanism and Side Effects

  • Qelbree (viloxazine) functions as a selective norepinephrine reuptake inhibitor, which increases norepinephrine levels in the brain and can trigger acute activation symptoms, including agitation, restlessness, and anxiety-like feelings, especially when treatment is first initiated 1
  • Adrenergic overstimulation can manifest as jitteriness or panic sensations, similar to what occurs with other noradrenergic medications, affecting 31.8% of patients on similar medications 2, 3

Management Strategies

  • The most appropriate immediate action is dose reduction rather than discontinuation, as agitation is typically dose-dependent and reversible, and the National Comprehensive Cancer Network recommends lowering the current dose to minimize noradrenergic overstimulation while maintaining therapeutic benefit 2
  • Ensuring Qelbree is taken with food may moderate absorption and reduce peak-related side effects, as suggested by Praxis Medical Insights 4
  • Monitoring for 2-4 weeks is recommended, since therapeutic effects and side effect tolerance often improve after this initial period, according to Praxis Medical Insights 4, 5

Common Pitfall to Avoid

  • Close monitoring during the first few days and weeks of treatment is specifically recommended because agitation can persist or worsen, and the National Comprehensive Cancer Network suggests that patients on similar noradrenergic medications experience jitteriness and hyperactivity, making this a common but manageable issue 2, 3

REFERENCES

1

Qelbree Mechanism and Efficacy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

psychostimulants for cancer-related fatigue. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

3

psychostimulants for cancer-related fatigue. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

4

Qelbree Administration and Monitoring [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Medication Addition to Existing Regimen [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025